A space for sharing and discussing news related to global current events, technology, and society.
69604 Members
We'll be adding more communities soon!
© 2020 Relevant Protocols Inc.
A space for sharing and discussing news related to global current events, technology, and society.
69604 Members
We'll be adding more communities soon!
© 2020 Relevant Protocols Inc.
Relevant
Hot
New
Spam
Relevant
Hot
New
Spam
0
29.4
0
29.4
>"Two doses failed to produce the hoped-for immune response among children aged 2 to 4 in a clinical trial. Research continues on whether three doses would be more effective for that age group."
>"Two doses failed to produce the hoped-for immune response among children aged 2 to 4 in a clinical trial. Research continues on whether three doses would be more effective for that age group."
Some low-ranking comments may have been hidden.
Some low-ranking comments may have been hidden.